[1]
B. Shi, “Chemically Programmable Antibody-Drug Conjugates: Strategies from Targeting Programmability to Payload Activation”, IJBLS, vol. 17, no. 2, pp. 228–238, Nov. 2026, doi: 10.54097/k2468v26.